BioSpace News Archive

Aerami Therapeutics, Inc. today announces the appointment of Lisa Yañez as chief operating officer.

Recently Announced 2022 U.S. Contract Wins Reinforce Focus on Quality of Life and Dignity.

Vivera Pharmaceuticals is pleased to welcome Fabio Macciardi, M.D., Ph.D., to its Advisory Board as Neurogenetics Scientific Advisor to the Company’s Biosciences Division.

Parexel, a leading global clinical research organization (CRO), today announced the launch of its Community Alliance Network, a novel program further integrating clinical research into the community healthcare setting to better serve patients and in turn create further opportunity for increased diversity in clinical trials.

GC Labs today announced that GC Labs and its affiliates including GC Cell, GC MS and GC Genome will participate in the IFCC WorldLab 2022 as a platinum sponsor held on 26-30 June 2022 at Coex Convention & Exhibition Center in Seoul.

The partnership aims to expand both companies’ footprint in the cardiac ultrasound imaging space.

NasoNeb®, Inc. is proud to announce their integration with Monaghan Medical Corporation in Plattsburgh, New York.

Cordis, a global leader in cardiovascular technologies, today announced the first-in-human use of the Radianz Radial Peripheral System™ by Jihad Mustapha, MD, FACC, FSCAI at Advanced Cardiac & Vascular Centers (ACV) in Grand Rapids, Michigan.

bit.bio, a synthetic biology company working on developing and providing any human cell type at scale, will present development and characterisation data on glutamatergic neurons, skeletal myocytes, microglia and associated disease models at this year’s International Society for Stem Cell Research Conference.

The Mark Foundation for Cancer Research announces a new ~$12 million grant to support a global team developing novel immunotherapies for children with solid tumors through Cancer Grand Challenges, an international funding initiative aiming to answer some of the biggest questions facing cancer research worldwide.